ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
批准号:
10178157
负责人:
Azra Bihorac
金额:
$61.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2026-04-30
关键词:
AcuteAddressAffectAlgorithmsBiological MarkersCircadian DysregulationCircadian desynchronyClinicalClinical DataClinical InformaticsCollaborationsComaComputing MethodologiesCritical CareCritical IllnessCuesDataData SetDeliriumElectronic Health RecordEnvironmentFosteringFoundationsFrequenciesHospital CostsHumanImageImpaired cognitionIntelligenceIntensive Care UnitsInterventionLightMedicalMedicineMissionModelingMonitorNeurologyNoiseObservational StudyOutcomePainPatient-Focused OutcomesPatientsPharmacologyPhysiciansPhysiologicalPreventionPrevention strategyProcessProviderPublic HealthReproducibilityResearchRisk FactorsSamplingSleep disturbancesSyndromeSystemTechniquesTechnologyTestingTimeUnited StatesUnited States National Institutes of Healthadvanced diseasebasebrain dysfunctioncircadiancircadian regulationclinical careclinical decision-makingcostdeep learningdeep learning algorithmdisease diagnosisdynamic systemhigh riskimprovedinnovationlight intensitymortalitynovelnovel strategiespatient mobilitypredictive modelingpressureprospectivereal time monitoringsatisfactionsensorsensor technologysoundtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Recent large-scale trials have shown no significant benefit of pharmacological interventions in delirium
patients, and non-pharmacological approaches remain the cornerstone of delirium prevention. Among those
strategies, minimizing patient immobility and circadian desynchrony are particularly difficult to implement, as
their assessment is dependent on sporadic human observations. The overall objective of this application is to
develop ADAPT, the Autonomous Delirium Monitoring and Adaptive Prevention system using novel pervasive
sensing and deep learning techniques. It will autonomously quantify patients’ mobility and circadian
desynchrony in terms of nightly disruptions, light intensity, and sound pressure level. This will allow for
integration of these risk factors into a dynamic model for predicting delirium trajectories. It will also enable
adaptive action prompts aimed at increasing patients’ mobility, reducing nightly disruptions, optimizing ambient
light, and reducing noise, based on precise real-time quantification. The rationale is that successful application
of the proposed technology would augment clinical-decision making in the fast-paced ICU environment and
would promote more targeted interventions. The overall objective will be achieved by pursuing three specific
aims. (1) Developing and validating an interpretable deep learning algorithm for precise and dynamic prediction
of the delirium trajectory, to determine if it is more accurate in predicting delirium trajectory transitions
compared to existing tools, while providing interpretable information to the physician. (2) Developing a
pervasive sensing system for autonomous monitoring of mobility and circadian desynchrony, to determine if it
can provide accurate assessments compared to human expert and circadian biomarkers, and if it can enrich
delirium trajectory prediction when combined with clinical data. (3) Developing and evaluating prompts for
adaptive delirium prevention using real-time monitoring system, to determine if the system has acceptable
satisfaction and perceived benefit among ICU physicians. The approach is innovative, because it represents
the first attempt to (1) dynamically predict precise delirium trajectory, (2) autonomously monitor mobility and
circadian desynchrony risk factors in the ICU, and (3) implement adaptive preventions in real time. The
proposed research is significant since it will address several key problems and critical barriers in critical care,
including (1) lack of precise and real-time delirium trajectory prediction models, (2) uncaptured aspects of
mobility and circadian desynchrony, and (3) the need for novel approaches for non-pharmacological
prevention. Ultimately, the results are expected to improve patient outcomes and decrease hospitalization
costs, as well as lifelong complications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bridge2AI: Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI
-
批准号:10858694
-
项目类别:
-
资助金额:$637.03万
-
财政年份:2022
-
负责人:Azra Bihorac
-
依托单位:
Bridge2AI: Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI
-
批准号:10472824
-
项目类别:
-
资助金额:$588.03万
-
财政年份:2022
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10414976
-
项目类别:
-
资助金额:$63.05万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10594086
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10396041
-
项目类别:
-
资助金额:$59.9万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10609525
-
项目类别:
-
资助金额:$63.56万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10154047
-
项目类别:
-
资助金额:$63.21万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10209005
-
项目类别:
-
资助金额:$56.22万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10580785
-
项目类别:
-
资助金额:$60.06万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10374834
-
项目类别:
-
资助金额:$59.49万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10602426
-
项目类别:
-
资助金额:$55.72万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
-
批准号:10445486
-
项目类别:
-
资助金额:$55.49万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
Integrating data, algorithms and clinical reasoning for surgical risk assessment
-
批准号:9233163
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
-
批准号:10681418
-
项目类别:
-
资助金额:$54.2万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8280337
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8076251
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8496075
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:7787562
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
海外基金